The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.4% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (27 analysts) rates it buy, with a mean price target of $121.
Expand Energy
EXE · a US exchange · USD · Market cap $20.5B · 1,600 employees
Expand Energy Corporation operates as an independent natural gas production company in the United States.
PASS · Titan Ethical · score 91.5Price as of 19 Nov 2026Daily close, not a live quote
Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price82.44 USD at the 19 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 19 Nov 2026
- Our regime readMarkdown, as of 16 Nov 2026
- Ethical screenPasses, score 91.5 out of 100
- OptionsOpen interest leans to puts (put/call 9.41)
- Last reviewed19 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $82.80 to $109.56, base estimate $95.27 (screen dated 2026-11-19).
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 9.41, read 2026-11-19
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
Expand Energy holds its Markdown at $82.44. Consolidating, no directional conviction, held for 167 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 167 days |
| Price at the screen | $82.44 |
| Valuation | 7.65 trailing · 10.93 forward price to earnings |
| Values screen | PASS · score 91.5 |
| Beta | 0.37 |
Five Screens: EXE's Results
PASS. All five recorded results clear their limits.
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 17.89% | Below 33% | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Pass |
| Receivables | 7.00% | Below 49% | Pass |
| Revenue purity | 0.17% | Below 5% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Clears, in Plain English
Expand Energy clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 18%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when EXE's ethical verdict changes
Today EXE passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 19 Nov 2026: it trades at roughly a 13% discount to our $95.27 fair value, moderate competitive moat, 11.60% revenue growth.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. A 13.5% discount to the base estimate.
Third-party analyst targets: 27 covering, consensus Buy. The average target sits +48% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $95.27, with a range of $82.80 to $109.56, dated to the 2026-11-19 screen.
How our estimate and third-party targets differ.
The Business, in Plain WordsGas producer priced for a downturn
Picture a US shale operator pulling gas out of the Marcellus while prices swing like a fairground ride. Expand Energy is doing exactly that, and the numbers show real momentum behind the business rather than just hope.
Revenue is up 41 percent, margins sit at 25 percent and return on equity reaches 18 percent. The forward multiple of 10.4 times earnings leaves an 11 percent margin of safety to our fair value, the moat is moderate and every analyst on the list carries a buy rating. It clears our ethical screen without issue.
Yet this remains a classic cyclical trap. Low multiples often appear right when earnings peak and the next down-cycle wipes them out. The shares look inexpensive only if volumes and prices hold; history says they rarely do. Analysis, not advice.
| Forward P/E | 10.9xfairly priced for its growth rate |
| Trailing P/E | 7.6xvery cheap relative to earnings |
| EPS, trailing | 11.59 |
| EPS, forward | 8.11 |
| Revenue growth | +11.6%steady growth |
| Profit margin | 21.3%healthy profit margins |
| Return on equity | 14.6%a solid return on shareholder capital |
| FCF yield | 6.68% |
| Dividend yield | 2.72% |
| Debt to equity | 0.24minimal debt: a conservative balance sheet |
| Current ratio | 0.90below 1: short-term bills exceed liquid assets |
| Beta | 0.37barely tracks the market's swings |
| Short interest, float | 0.05% |
| 52-week range | 83.25 - 126.62 |
| Moat | MODERATE |
| Market cap | $20.5B |
| Employees | 1,600 |
Metric definitions and interpretation rules: ticker-page methodology.
Titan Case StudyOur full written analysis of EXE: Expand Energy (EXE) — Accumulation in America’s Natural Gas Giant → 2026-07-01
Every Entry, As Written
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 3.9% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (27 analysts) rates it buy, with a mean price target of $123.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 4.2% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (27 analysts) rates it buy, with a mean price target of $123.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (27 analysts) rates it buy, with a mean price target of $123. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (27 analysts) rates it buy, with a mean price target of $123. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (27 analysts) rates it buy, with a mean price target of $123. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (27 analysts) rates it buy, with a mean price target of $123. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (28 analysts) rates it buy, with a mean price target of $123. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (28 analysts) rates it buy, with a mean price target of $123. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (28 analysts) rates it buy, with a mean price target of $122. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Expand Energy: 3 Key Takeaways for Long-Term Investors Yahoo Finance · 11d ago
- Diamondback Just Raised Its Dividend 7.3%. These 3 Energy Stocks Are Paying Investors Too Yahoo Finance · 14d ago
- Why Is Everyone Ignoring Expand Energy Stock's High Cash Yield? Yahoo Finance · 14d ago
- Billionaire Howard Marks’ AI Warning and Top 5 Non-AI Stock Picks Yahoo Finance · 20d ago
- EXE Q3 deep dive: Integration, new CEO, and commercial expansion define the quarter Yahoo Finance · 20d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-07 | TEUNISSEN MARCEL | Chief Financial Officer | 2,000 | $192,860 | |
| 2026-04-06 | TEUNISSEN MARCEL | Chief Financial Officer | 5,144 | · | |
| 2026-03-13 | LACY CHRISTOPHER W | General Counsel | 5,693 | · | |
| 2026-03-13 | VIETS JOSHUA J | Chief Financial Officer | 10,815 | · | |
| 2026-03-13 | LARSON GREGORY M | Officer | 2,372 | · | |
| 2026-03-13 | TURCO DANIEL F | Officer | 5,693 | · | |
| 2026-03-13 | RAIFORD BRITTANY | Chief Financial Officer | 3,558 | · | |
| 2026-03-13 | VIETS JOSHUA J | Chief Financial Officer | 14,736 | · | |
| 2026-03-13 | LARSON GREGORY M | Officer | 953 | · | |
| 2026-03-06 | WICHTERICH MICHAEL A. | Chief Executive Officer | 2,000 | $215,000 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-09-25 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-08-18 | Michael McCaul | Republican | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $92.32 | -8.5% | $0.58 | $921 | -7.9% |
| 2 months | $86.92 | -2.8% | $0.58 | $978 | -2.2% |
| 3 months | $95.45 | -11.5% | $0.58 | $891 | -10.9% |
| 6 months | $96.72 | -12.7% | $1.15 | $885 | -11.5% |
| 1 year | $114.38 | -26.2% | $2.30 | $759 | -24.1% |
| 2 years | $91.26 | -7.4% | $5.49 | $986 | -1.4% |
| 3 years | $75.02 | +12.6% | $7.93 | $1,232 | +23.2% |
| 5 years | $48.58 | +73.9% | $21.58 | $2,183 | +118.3% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever EXE does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.